Obesity, hypertension, and vascular disease
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Obesity, hypertension, and related metabolic and hemodynamic abnormalities contribute significantly to cardiovascular disease in westernized societies such as the United States. Both obesity and hypertension are more prevalent among minorities such as black and Hispanic populations. Obesity substantially increases the likelihood of hypertension, and weight reduction has been shown to be an effective hygienic measure in reducing blood pressure. There is accumulating evidence that central obesity, particularly obesity that is distributed in the paraomental (visceral) region, especially predisposes one to hypertension and related metabolic abnormalities that contribute cerebrovascular disease.
- Fukagawa NK, Bandini LG, Young JB: Effect of age on body composition and resting metabolic rate. Am J Physiol 1990, 2159:E233-E238.
- Sowers JR, Sowers PS, Peuler JD: Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 1994, 123:647–652.
- Poelman ET, Toth MJ, Bunyard LB, et al.: Physiological predictions of increasing total and central adiposity in aging men and women. Arch Intern Med 1995, 155:2443–2448. CrossRef
- Zamboni M, Armellini F, Milani MP: Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables and their inter-relationships. Int J Obesity 1992, 16:495–504.
- Carey DG, Jenkins AB, Campbell LV, et al.: Abdominal fat and insulin resistance in normal and overweight women. Diabetes 1996, 45:633–638. CrossRef
- Dowling HJ, Pi-Sunyer FX: Race dependent health risks of upper-body obesity. Diabetes 1993, 42:537–543. CrossRef
- Albu JB, Murphy L, Frager DH, et al.: Visceral fat and racedependent health risk in obese nondiabetic premenopausal women. Diabetes 1997, 46:456–462. Upper body obesity is black premenopausal women has less metabolic complications than in white women because black women accumuate more subcutaneous fat than visceral fat. CrossRef
- Banerji MA, Lebowitz J, Charken RL, et al.: Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol 1997, 273:E425-E432. Black noninsulin-dependent diabetics are the only group in which visceral fat causes equal metabolic disturbances in men and women.
- Kohrt WM, Obert KA, Holloszy JO: Exercise training improves fat distribution patterns in 60- to 70-year-old men and women. J Gerontol 1992, 47:M99-M105.
- Troisi RJ, Heinold JW, Vokonas PS, Weiss ST: Cigarette smoking, dietary intake, and physical activity: effects on body fat distribution: the Normative Aging Study. Am J Clin Nutr 1991, 53:1104–1111.
- Wing RR, Matthews KA, Culler LH, et al.: Waist to hip ration in middle-aged women: associations with behavioral and psychological factors and with changes in cardiovascular risk factors. Arterioscler Thromb 1991, 11:1250–1257.
- Schwartz RS, Shuman WP, Larson V: The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism 1991, 40:545–551. CrossRef
- Folsom AR, Kaye SA, Sellers TA. Body fat distribution and 5-year risk of death in older women. JAMA 1993, 269:483–487. CrossRef
- Zamboni M, Armellini F, Milani MP: Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships. Int J Obesity 1992, 16:495–504.
- Busby MJ, Bellantoni MJ, Tobin JD, et al.: Glucose tolerance in women: the effects of age, body composition, and sex hormones. J Am Geriatr Soc 1992, 40:497–502.
- Landin K, Lönnroth M, Krotkiewski M, et al.: Increased insulin resistance and fat cell lipolysis in obese but not lean women with a high waist/hip ratio. Eur J Clin Invest 1990, 20:530–536. CrossRef
- Bonaro E, DelPrato S, Bonadonna G: Total body fat content and fat topography are associated differently with in vivo glucose metabolism in non-obese and obese nondiabetic women. Diabetes 1992, 41:1151–1159. CrossRef
- Flack JM, Sowers JR: Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med 1991, 91(suppl 1A):11S-21S. CrossRef
- Sowers JR: Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998, 158:617–621. First complete review of how much of an impact diabetes mellitus has on CVD in women. CrossRef
- Bonham GS, Brock DB: The relationship of diabetes with race, sex and obesity. Am J Clin Nutr 1985, 41:776–783.
- Manolio TA, Pearson TA, Wenger NK: Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol 1992, 2:161–176. CrossRef
- Dowling HJ, Pi-Sunyer FX: Race dependent health risks of upper-body obesity. Diabetes 1993, 42:537–543. CrossRef
- Pouliot MC, Després JP, Nadeau A, et al.: Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992, 41:826–834. CrossRef
- Spiegelman D, Israel RG, Bouchard C, Willett WC: Absolute fat mass, percent body fat, and body-fat distribution: which is the real determinant of blood pressure and serum glucose? Am J Clin Nutr 1992, 55:1033–1044.
- Björntorys P: Abdominal fat distribution and disease: an overview of epidemiology data. Ann Med 1992, 24:15–18. CrossRef
- Tchernof A, Lamarchi B, Prud’homme A. The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996, 19:629–637. CrossRef
- Goodpaster BH, Thaete FL, Simoneau JA, Kelley D:. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997, 46:1579–1585. CrossRef
- Abate N, Garg A, Peshock RM, et al.: Relations of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995, 96:88–98. CrossRef
- Abate N, Garg Q, Peshock RM, et al.: Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996,:1684–1693.
- Sowers JR, Sokol RJ, Standley PR, et al.: Insulin resistance and increased body mass index in women developing hypertension in pregnancy. Nutr Metab Cardiovasc Dis 1996, 6:141–146.
- Conway NJ, Janovski SZ, Avila NA, Hubbard VS: Visceral adipose tissue differences in black and white women. Am J Clin Nutr 1995, 61:765–771.
- Lovejoy JC, Bretonne JA Klemperer M, Tulley R: Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996, 45:1119–1124. CrossRef
- Sowers JR. Obesity and cardiovascular disease. Clin Chem 1998, 44:B1821-B1825.
- Lamarche B, Moorjani S, Lupien PJ, et al.: Apolipoprotein A-1 and B levels and the risk of ischemic heart disease during a five year follow-up of men in the Quebec Cardiovascular Study. Circulation 1996, 94:273–278.
- Després JP, Lamarche B, Mauriège P, et al.: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952–957. CrossRef
- Sowers JR, Epstein M: Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension 1995, 26:869–879.
- UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703–713.
- Joint National Committee: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413–2446. CrossRef
- Hoffstedt J, Wahrenberg H, Thorne A, Lönnqvist F: The metabolic syndrome is related to beta 3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia 1996, 39:838–844. CrossRef
- Hoffstedt J, Arner P, Hellers G, Lönnqvist F: Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J Lipid Res 1997, 38:795–804.
- Mauriège P, Prud’homme D, Lemieux S, et al.: Regional differences in adipose tissue lipolysis from lean and obese women: existence of postreceptor alterations. Am J Physiol 1995, 269:E341-E350.
- Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997, 29:691–699.
- Fontbonne A, Charles MA, Thibult N, et al.: Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991, 34:356–361. CrossRef
- Welin L, Eriksson H, Larsson B, et al.: Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia 1992, 35:766–770.
- Haragreaves AD, Logan RL, Elton RA, et al.: Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year followup and development of coronary heart disease in Edinburgh men. Atherosclerosis 1992, 94:61–69. CrossRef
- Ferrara LA, Mancini M, Celentano A, et al.: Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients. Arterioscler Thromb 1994, 14:1290–1296.
- Folsom AR, Eckfeldt JH, Weitzman S, et al.: Atherosclerosis risk in communities (ARIC) study investigators: relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 1994, 25:66–73.
- Salomaa V, Riley W, Kark JD, et al.: Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC study. Circulation 1995, 91:1432–1443.
- Agewall S, Fagerberg B, Attvall S, et al.: Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke 1995, 26:956–960.
- Shinozaki K, Suzuki M, Ikebuchi M, et al.: Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 1995, 92:1749–1757.
- Shinozaki K, Naritomi H, Shimizu T, et al.: Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996, 27:37–43.
- Suzuki M, Shinozaki K, Kanazawa A, et al.: Insulin resistance as an independent risk for carotid wall thickening. Hypertension 1996, 28:593–598.
- Walsh MF, Dominguez LJ, Sowers JR: Metabolic abnormalities in cardiac ischemia. Cardiol Clin 1995, 13:529–538.
- Eggena P, Sowers JR, Maxwell MH, et al.: Hormonal correlates of weight loss associated with blood pressure reduction. Clin Exp Hypertens 1991, 13:1447–1456.
- Scherrer U, Nussberger J, Torriani S, et al.: Effect of weight reduction in moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium. Circulation 1991, 83:552–558.
- Jacobs DB, Sowers JR, Hmeidan A, et al.: Effects of weight reduction and cellular cation metabolism and vascular resistance. Hypertension 1993, 21:308–314.
- Landsberg L: Obesity and hypertension: experimental data. J Hypertens 1992, 10(suppl l7):S195-S201. CrossRef
- Istfan NW, Plaisted CS, Bistrian BR, Blackburn GL: Insulin resistance versus insulin secretion in the hypertension of obesity. Hypertension 1992, 19:385–392.
- Bakris G, Weir MR, Sowers J: Therapeutic challenges in the obese diabetic patient with hypertension. Am J Med 1996, 101:33S-46S. CrossRef
- Van Gaal LF, Wanters T, DeLeeuw IH: The beneficial effects of modest weight loss on cardiovascular risk factors. Intern J Obesity 1997, 21:S5-S9. This study emphasizes that only a 5% to 15% loss of baseline weight in obesity can normalize many risk factors.
- Sower JR: Modest weight gain and the development of diabetes: another perspective. Ann Intern Med 1995, 122:548–549.
- Obesity, hypertension, and vascular disease
Current Hypertension Reports
Volume 1, Issue 2 , pp 140-144
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links
- Industry Sectors